BIA
CRL icon

Bell Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Bell Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.07K Hold
40
– – ﹤0.01% 738
2026
Q1 		$6.9K Buy
40
+3
+8% +$556 ﹤0.01% 827
2025
Q4 		$7.38K Sell
37
-13
-26% -$2.36K ﹤0.01% 815
2025
Q3 		$7.82K Buy
50
+7
+16% +$1.11K ﹤0.01% 727
2025
Q2 		$6.53K Hold
43
– – ﹤0.01% 855
2025
Q1 		$6.47K Buy
43
+12
+39% +$2.01K ﹤0.01% 792
2024
Q4 		$5.72K Sell
31
-11
-26% -$2.12K ﹤0.01% 868
2024
Q3 		$8.27K Sell
42
-6
-13% -$1.25K ﹤0.01% 696
2024
Q2 		$9.92K Hold
48
– – ﹤0.01% 614
2024
Q1 		$13K Sell
48
-9
-16% -$2.15K ﹤0.01% 494
2023
Q4 		$13.5K Buy
57
+8
+16% +$1.57K ﹤0.01% 457
2023
Q3 		$9.6K Sell
49
-1
-2% -$205 ﹤0.01% 522
2023
Q2 		$10.5K Buy
50
+1
+2% +$199 ﹤0.01% 498
2023
Q1 		$9.89K Sell
49
-2
-4% -$453 ﹤0.01% 487
2022
Q4 		$11.1K Buy
51
+10
+24% +$2.18K ﹤0.01% 458
2022
Q3 		$8K Sell
41
-22
-35% -$4.75K ﹤0.01% 479
2022
Q2 		$13K Buy
+63
New +$15.4K ﹤0.01% 359
2021
Q4 		$16K Sell
43
-3
-7% -$1.17K ﹤0.01% 360
2021
Q3 		$19K Buy
+46
New +$19.1K 0.01% 294

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Bell Investment Advisors's CRL Position: Q2 2026 in Review

Bell Investment Advisors held its Charles River Laboratories (CRL) position steady in Q2 2026 at 40 shares worth $9.07K. The position accounts for ﹤0.01% of the portfolio, ranked #738.

Bell Investment Advisors first reported a position in CRL in Q3 2021 and has held it in 19 quarters since. The position peaked at $19K in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Bell Investment Advisors held 40 shares of Charles River Laboratories worth $9.07K as of Q2 2026.
  • Bell Investment Advisors left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #738 holding.
  • Bell Investment Advisors first reported a position in Charles River Laboratories in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Charles River Laboratories position peaked at $19K in Q3 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.